Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Alan S.L. Yu"'
Autor:
Mireille El Ters, Pengcheng Lu, Jonathan D. Mahnken, Jason R. Stubbs, Shiqin Zhang, Darren P. Wallace, Jared J. Grantham, Arlene B. Chapman, Vicente E. Torres, Peter C. Harris, Kyongtae Ty Bae, Douglas P. Landsittel, Frederic F. Rahbari-Oskoui, Michal Mrug, William M. Bennett, Alan S.L. Yu
Publikováno v:
Kidney International Reports, Vol 6, Iss 4, Pp 953-961 (2021)
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst growth and a loss of functioning renal mass, but a decline in glomerular filtration rate (GFR) and onset of end-stage renal disease (ESRD) occur l
Externí odkaz:
https://doaj.org/article/8beb5b69c3a14ce4bc60ffbad23c4ea5
Autor:
Alan S.L. Yu, Douglas P. Landsittel
Publikováno v:
Advances in Kidney Disease and Health. 30:285-293
Autor:
Brenda S. Magenheimer, Joseph S. Tash, Xiaogang Li, Darren P. Wallace, Sudhakar Jakkaraj, Shirin V. Sundar, Gail A. Reif, Gunda I. Georg, James P. Calvet, Xia Zhou, Alan S.L. Yu
Publikováno v:
American Journal of Physiology-Renal Physiology. 323:F492-F506
Autosomal dominant polycystic kidney disease (ADPKD) is a debilitating renal neoplastic disorder with limited treatment options. It is characterized by the formation of large fluid-filled cysts that develop from kidney tubules through abnormal cell p
Autor:
Eden A. Houske, Matthew G. Glimm, Annika R. Bergstrom, Sally K. Slipher, Hope D. Welhaven, Mark C. Greenwood, Greta M. Linse, Ronald K. June, Alan S.L. Yu, Darren P. Wallace, Alyssa K. Hahn
Publikováno v:
American Journal of Physiology-Renal Physiology.
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of numerous fluid-filled cysts that lead to progressive loss of functional nephrons. Currently, there is an unmet need for diagnostic and prognostic indicators of
Autor:
Adriana V. Gregory, Fouad T. Chebib, Bhavya Poudyal, Heather L. Holmes, Alan S.L. Yu, Douglas P. Landsittel, Kyongtae T. Bae, Arlene B. Chapman, Rahbari-Oskoui Frederic, Michal Mrug, William M. Bennett, Peter C. Harris, Bradley J. Erickson, Vicente E. Torres, Timothy L. Kline
Publikováno v:
Kidney International.
Autor:
Berenice Gitomer, Kaleab Z. Abebe, Michel Chonchol, Alan S.L. Yu, Kristen L. Nowak, William E. Braun, Peter C. Harris, Vicente E. Torres, Ronald D. Perrone, Godela Brosnahan, Cortney N. Steele, Arlene B. Chapman, Zhiying You, Theodore I. Steinman
Publikováno v:
Kidney International Reports
Autor:
Mohamad A. Kalot, Diana Jalal, Mohammad Al Khatib, Nedaa Husainat, Kerri McGreal, Alan S.L. Yu, Abdallah El Alayli, Reem A. Mustafa
Publikováno v:
Kidney360
Background A computable phenotype is an algorithm used to identify a group of patients within an electronic medical record system. Developing a computable phenotype that can accurately identify patients with autosomal dominant polycystic kidney disea
Autor:
Shiqin Zhang, Kyongtae T. Bae, Vicente E. Torres, William M. Bennett, Douglas Landsittel, Frederic F. Rahbari-Oskoui, Jared J. Grantham, Jason R. Stubbs, Pengcheng Lu, Mireille El Ters, Jonathan D. Mahnken, Darren P. Wallace, Peter C. Harris, Michal Mrug, Alan S.L. Yu, Arlene B. Chapman
Publikováno v:
Kidney International Reports, Vol 6, Iss 4, Pp 953-961 (2021)
Kidney International Reports
Kidney International Reports
Introduction Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst growth and a loss of functioning renal mass, but a decline in glomerular filtration rate (GFR) and onset of end-stage renal disease (ESRD) occur la
Publikováno v:
Curr Opin Nephrol Hypertens
PURPOSE OF THE REVIEW: Progressive forms of chronic kidney disease (CKD) exhibit kidney inflammation and fibrosis that drive continued nephron loss; however, factors responsible for the development of these common pathologic features remain poorly de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f28a5f1f8a61e76773e25c1406a78b1
https://europepmc.org/articles/PMC9232955/
https://europepmc.org/articles/PMC9232955/
Autor:
Michel Chonchol, Anna Jovanovich, Charles E. Robertson, Thomas D. Nolin, Bryan Kestenbaum, Andrew N. Hoofnagle, Daniel N. Frank, Alexander J. Prokopienko, Jason R. Stubbs, Shiqin Zhang, Cassandra Johnson, Raymond E. West, Diana Ir, Cassandra Kimber, Makoto Miyazaki, Jonathan D. Mahnken, Alan S.L. Yu
Publikováno v:
Kidney360
Background Recent evidence suggests the systemic accumulation of by-products of gut microbes contributes to cardiovascular morbidity in patients with CKD. Limiting the generation of toxic bacterial by-products by manipulating the intestinal microbiot